<bill session="106" type="h" number="5119" updated="2013-07-14T18:55:07-04:00">
  <state datetime="2000-09-06">REFERRED</state>
  <status>
    <introduced datetime="2000-09-06"/>
  </status>
  <introduced datetime="2000-09-06"/>
  <titles>
    <title as="introduced" type="short">Health Care Liability Reform Act</title>
    <title as="introduced" type="official">To provide for health care liability reform.</title>
  </titles>
  <sponsor id="400404"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2000-09-06">
      <text>Referred to the House Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Consumer education"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Evidence (Law)"/>
    <term name="Federal preemption"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Law"/>
    <term name="Medical malpractice"/>
    <term name="Medical supplies"/>
    <term name="Products liability"/>
    <term name="Punitive damages"/>
    <term name="State laws"/>
  </subjects>
  <amendments/>
  <summary>9/6/2000--Introduced.
Health Care Liability Reform Act - Permits punitive damages, to the extent permitted by applicable State law, to be awarded against a manufacturer or product seller in a civil action if the claimant establishes by clear and convincing evidence that the harm suffered was the result of conduct manifesting actual malice.Prohibits the manufacturer of a prescription drug or device and a health care provider from being subject to punitive damages with respect to harm caused by a drug or device if the drug or device was approved under the Federal Food, Drug, and Cosmetic Act unless: (1)the manufacturer withholds from the Food and Drug Administration; or (2) the health care provider withholds from a patient, information which is relevant to the performance of the drug or device and causally related to the harm suffered by the plaintiff.</summary>
</bill>
